Biogen Says To High Court: Interference Appeals Not Limited To Federal Circuit

(December 10, 2015, 2:30 PM EST) -- WASHINGTON, D.C. — In a petition filed Nov. 9 asking the U.S. Supreme Court to review a decision giving an appeals court exclusive jurisdiction over appeals of patent interference decisions and barring district courts from hearing them, Biogen MA Inc. argues that the appellate court misread the Leahy-Smith America Invents Act (AIA) (Biogen MA, Inc. v. Japanese Foundation for Cancer Research and Bayer Pharma AG, No. 15-607, U.S. Sup.).

(Petition for writ of certiorari available. Document #78-151214-008B.)

Biogen MA Inc. sued Japanese Foundation for Cancer Research...
To view the full article, register now.